In reviewing 2025 trends from advisory opinions issued by the Department of Health and Human Services’ Office of Inspector General (OIG), ...

In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.

President Donald Trump’s direct-to-consumer drug platform — which prominently features an image of him in the Oval Office — ...

On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued a Special Advisory Bulletin ...

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...

Three Democrats cite possible conflicts of interest in letter to HHS inspector general ...

The former vice chancellor and his co-defendants were arraigned on five counts of bribery, to which they pleaded not guilty.

The Office of Inspector General's bulletin provides a framework for pharma companies selling prescription ...

Senators Durbin, Warren, and Welch challenge TrumpRx's launch, citing concerns over pharma kickbacks, telehealth misuse, and ...

Concerns about nursing homes’ reporting of medical directors’ hours using the Payroll-Based Journal system have raised questions about whether they are actually integral to implementing resident care ...

TrumpRx launch delayed as HHS issues new guidance on direct drug sales, affecting discounted prescription drug access for Americans.

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...